Where L.A. County residents aged 50 and older can get another booster starting Wednesday

Some Los Angeles County-operated vaccination websites will start providing a second booster dose to residents aged 50 and older beginning Wednesday, officers introduced.

The transfer comes after the U.S. Meals and Drug Administration on Tuesday licensed one other booster shot of Moderna or Pfizer’s COVID-19 vaccines for the age group.

The fourth dose of the Pfizer or Moderna vaccines may be taken at the very least 4 months after the earlier booster.

As of now, solely a choose few L.A. County vaccination websites can be administering second booster doses for these aged 50 and older. They embody:

• Obregon Park in East Los Angeles
• Ted Watkins Park in South Los Angeles
• Balboa Sports activities Advanced in Encino
• Commerce Senior Residents Middle in Commerce
• Market Avenue Middle in Santa Clarita
• Palmdale Oasis Recreation Middle

Eligible residents may verify with their well being care suppliers and native pharmacies about getting the second booster dose.

Extra info on getting vaccinated in L.A. County may be discovered right here.

Beforehand, the fourth COVID-19 vaccine dose was solely licensed for individuals 12 and older who’ve weakened immune techniques.

Increasing the authorization to these aged 50 and older will make tens of millions extra eligible to get a fourth shot to shore up their safety towards COVID-19.

The FDA mentioned the second booster dose might assist improve safety for the higher-risk group.

Whereas coronavirus circumstances have been declining in L.A. County and throughout the U.S. following the winter surge, there was fears that the tremendous extremely omicron variant, BA.2, might convey an infection numbers again up. 

“Present proof suggests some waning of safety over time towards severe outcomes from COVID-19 in older and immunocompromised people. Primarily based on an evaluation of rising information, a second booster dose of both the Pfizer-BioNTech or Moderna COVID-19 vaccine might assist improve safety ranges for these higher-risk people,” mentioned Dr. Peter Marks of the FDA.